BackTable Urology
Ep. 210 Personalizing ADT Across the Prostate Cancer Spectrum with Dr. Rana McKay
Dr. Rana McKay
Yeah, you know, I think that's a very good question. You know, I think at the end of the day, it depends on the patient's symptoms, their goals of care, their quality of life. I think if there's somebody that is maybe has high risk localized disease, the treatment's going to be resultant in a lot of morbidity from surgery or morbidity from radiation.
0
💬
0
Comments
Log in to comment.
There are no comments yet.